Mapracorat
Mapracorat
Mapracorat (pronounced: ma-pra-co-rat) is a type of non-steroidal anti-inflammatory drug (NSAID) that is classified as a glucocorticoid receptor agonist. It is primarily used in the treatment of inflammatory and autoimmune diseases.
Etymology
The term "Mapracorat" is derived from the combination of the words "map" and "racorat". The "map" part of the name is an acronym for "molecularly activated protein", which refers to the drug's mechanism of action. The "racorat" part of the name is a coined term with no specific etymological origin.
Mechanism of Action
Mapracorat works by binding to the glucocorticoid receptor, a type of nuclear receptor that is activated by the steroid hormone cortisol. Once activated, the receptor can regulate the expression of specific genes, which can help to reduce inflammation and immune responses.
Related Terms
- Glucocorticoid receptor: A type of nuclear receptor that is activated by the steroid hormone cortisol.
- Non-steroidal anti-inflammatory drug (NSAID): A class of drugs that provide analgesic and antipyretic effects, and in higher doses, anti-inflammatory effects.
- Inflammatory diseases: Diseases characterized by inflammation, such as rheumatoid arthritis and lupus.
- Autoimmune diseases: Diseases in which the body's immune system attacks healthy cells.
External links
- Medical encyclopedia article on Mapracorat
- Wikipedia's article - Mapracorat
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski